Michael Edenfield
Family · Swainsboro, GANPI 1851767214
Payments from drug & device makers
Across 116 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$259
- AbbVie$258
- Novo Nordisk$240
- Lilly USA, LLC$171
- Sanofi-aventis U.S. LLC$150
- Novartis$85
- plus $661 from 20 others
What the payments were for
- Food & beverage$1,824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $259 |
| AbbVie | 16 | $258 |
| Novo Nordisk | 22 | $240 |
| Lilly USA, LLC | 10 | $171 |
| Sanofi-aventis U.S. LLC | 8 | $150 |
| Novartis | 5 | $85 |
| Daiichi Sankyo Inc. | 5 | $84 |
| GSK | 5 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $57 |
| Biogen | 2 | $40 |
| Johnson & Johnson | 3 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Exact Sciences | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Scpharmaceuticals Inc. | 2 | $31 |
| Eisai Inc. | 2 | $31 |
| Pfizer | 2 | $31 |
| Lundbeck LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Merck | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Edwards Lifesciences | 1 | $15 |
| Amgen | 1 | $13 |
How this compares
$1,824 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 77 | $72,642 |
| OzempicSemaglutide | 39 | $49,540 |
| MounjaroTirzepatide | 29 | $39,112 |
| LinzessLinaclotide | 55 | $34,031 |
| EliquisApixaban | 77 | $27,231 |
| TrulicityDulaglutide | 21 | $23,998 |
| FarxigaDapagliflozin Propanediol | 19 | $18,654 |
| Tresiba Flextouch U-200Insulin Degludec | 28 | $18,260 |
| JanuviaSitagliptin Phosphate | 18 | $11,381 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,143 |
| Humalog Kwikpen U-200Insulin Lispro | 11 | $8,967 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $8,515 |
| SynjardyEmpagliflozin/Metformin Hcl | 12 | $7,093 |
| MyrbetriqMirabegron | 11 | $6,021 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,951 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy | $37 | $79,73689 claims |
| Lilly USA, LLCMounjaro, Trulicity | $171 | $63,11050 claims |
| Novo NordiskOzempic | $240 | $49,54039 claims |
| AbbVieLinzess, Synthroid | $258 | $36,30694 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $259 | $33,22849 claims |
| PfizerEliquis | $31 | $27,23177 claims |
| MerckJanuvia | $17 | $11,38118 claims |
| GSKAnoro Ellipta | $80 | $8,51516 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $57 | $4,70412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.
Other family in Swainsboro
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.